Start a new search
Other sectors:
About Kellysearch
Executive Director, Investor Relations and Corporate Communications in Wilmington, NC, US (United States)
Company Overview:
PPD is an international contract research organization that specializes in clinical trial management for the pharmaceutical, biotechnology and medical industries.
Company Statistics:
ViewContact Details
Address:3151 South 17th Street, Wilmington, NC, 28412, United States
Telephone:
Fax:
Sponsored Links
News:
Allegheny Energy Inc. Q3 2009 Earnings Call Transcript (at Seeking Alpha)
News
|
...Officer Max Kuniansky – Executive Director, Investor Relations and Corporate Communications Analysts Daniel Eggers...conference over to Max Kuniansky, Executive Director, Investor Relations and Corporate Communications. Mr. Kuniansky, please...
Allegheny Power Announces Decision on Environmental Project Financing in West Virginia...
News
|
...233-3583 E-mail: astagge@alleghenyenergy.com or Investor contact Max Kuniansky, Executive Director, Investor Relations and Corporate Communications, 724-838-6895 E-mail: mkunian@alleghenyenergy.com Related terms: accounting...
ImmunoGen, Inc. Licenses Anticancer Technology to Amgen ; Deal Worth up to $35 Million...
News
|
...Exchange Commission. Contact: ImmunoGen, Inc. Carol Hausner, 781-895-0600 Executive Director, Investor Relations and Corporate Communications info@immunogen.com Read at Reuters Read at BioSpace.com • Reuters • BioSpace...
Allegheny Energy Announces Approval of Purchased Power Costs in Virginia - Yahoo! Fina...
News
|
GREENSBURG, Pa.--(BUSINESS WIRE)--Allegheny Energy, Inc. (NYSE: AYE - News) announced today that the Virginia State Corporation Commission has approved,
Allegheny Energy Inc. Q3 2009 Earnings Call Transcript
Blog
|
...Officer Max Kuniansky – Executive Director, Investor Relations and Corporate Communications Analysts Daniel Eggers...conference over to Max Kuniansky, Executive Director, Investor Relations and Corporate Communications. Mr. Kuniansky, please...
Press Releases:
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcomi...
Press Release
|
...Commission. SOURCE: ImmunoGen, Inc. ImmunoGen, Inc. Carol Hausner, 781-895-0600 Executive Director, Investor Relations and Corporate Communications info@immunogen.com Related terms: biology, cancer, ceo, clinical, connecticut...
Allegheny Energy Announces Approval of Purchased Power Costs in Virginia - Zibb.com
Press Release
|
...dcolafe@alleghenyenergy.com or Investor contact: Max Kuniansky, 724-838-6895 Executive Director, Investor Relations and Corporate Communications E-mail: mkunian@alleghenyenergy.com Related terms: accounting, business, coal...
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's...
Press Release
|
...Commission. SOURCE: ImmunoGen, Inc. ImmunoGen, Inc. Carol Hausner, 781-895-0600 Executive Director, Investor Relations and Corporate Communications info@immunogen.com Related terms: annual report, biology, biotechnology, cancer...
ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the T...
Press Release
|
...Commission. SOURCE: ImmunoGen, Inc. ImmunoGen, Inc. Carol Hausner, 781-895-0600 Executive Director, Investor Relations and Corporate Communications info@immunogen.com Related terms: annual report, biology, cancer, clinical...
ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other ...
Press Release
|
...com. SOURCE: ImmunoGen, Inc. ImmunoGen, Inc. Carol Hausner, 781-895-0600 Executive Director, Investor Relations and Corporate Communications info@immunogen.com Related terms: acquisition, biology, biotechnology, business...
Web Pages:
Contact PPD: Investor Information
Web
|
...Investor Information For Investor Information Contact Information Stephen Smith Executive Director, Investor Relations and Corporate Communications PPD, Inc. Corporate Headquarters 3151 South 17th Street Wilmington, NC 28412...
Amgen Incorporated Company Details from the Legal Industry
Web
|
...Commission. SOURCE: ImmunoGen, Inc. ImmunoGen, Inc. Carol Hausner, 781-895-0600 Executive Director, Investor Relations and Corporate Communications info@immunogen.com Read more... Tags: annual report biology biotechnology...
Pharmacy Choice - Pharmaceutical News - Pediatric Indication Approved - June 25, 2007...
Web
|
...Adam C. Derbyshire, Senior Vice President and Chief Financial Officer or Mike Freeman, Executive Director, Investor Relations and Corporate Communications, 919-862-1000 KEYWORD: NORTH CAROLINA INDUSTRY KEYWORD: ADVERTISING/MARKETING...
Salix Pharmaceuticals, Ltd.'s MoviPrep(R) Issued Approvable Letter By FDA - News, Sear...
Web
|
...1000 Senior Vice President and Chief Financial Officer or Mike Freeman, 919-862-1000 Executive Director, Investor Relations and Corporate Communications Source: Salix Pharmaceuticals, Ltd. Read Article at Related Companies News...
Industry News Feeds : Press Room : Micromedex
Web
|
...Commission. CONTACT: Investors ImmunoGen, Inc. Carol Hausner, 617-995-2500 Executive Director, Investor Relations and Corporate Communications info@immunogen.com or Media KMorrisPR Kathryn Morris, 845-635-9828 Kathryn@kmorrispr...
IT Products & Services:
- Business Products and Services
- Computing
Sponsored Links
Data Distributors, Inc.
Mainframe Outsourcing, Timesharing and Software Development Support
Related Companies:
Sponsored Links
Outsourcing services
Innovative outsourcing solutions
to help you improve your Business
24/7 Monitor & Tech Ops
IT shared services optimal for SMB
Fast startup & short term options.
